Gap junction alpha-4 protein, also known as Connexin-37 or Cx37, is a protein that in humans is encoded by the GJA4gene.[1][2][3] This protein, like other Connexin proteins, forms connections between cells known as gap junctions. Connexin 37 can be found in many tissues including the ovary[4], heart[5], and kidney[6].
References
↑Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH, DiGiovanna JJ, Compton JG, Bale SJ (December 1998). "Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis". Nature Genetics. 20 (4): 366–9. doi:10.1038/3840. PMID9843209.
Beyer EC, Paul DL, Goodenough DA (July 1990). "Connexin family of gap junction proteins". The Journal of Membrane Biology. 116 (3): 187–94. doi:10.1007/BF01868459. PMID2167375.
Haefliger JA, Bruzzone R, Jenkins NA, Gilbert DJ, Copeland NG, Paul DL (January 1992). "Four novel members of the connexin family of gap junction proteins. Molecular cloning, expression, and chromosome mapping". The Journal of Biological Chemistry. 267 (3): 2057–64. PMID1370487.
Willecke K, Jungbluth S, Dahl E, Hennemann H, Heynkes R, Grzeschik KH (December 1990). "Six genes of the human connexin gene family coding for gap junctional proteins are assigned to four different human chromosomes". European Journal of Cell Biology. 53 (2): 275–80. PMID1964417.
Van Camp G, Coucke P, Speleman F, Van Roy N, Beyer EC, Oostra BA, Willems PJ (November 1995). "The gene for human gap junction protein connexin37 (GJA4) maps to chromosome 1p35.1, in the vicinity of D1S195". Genomics. 30 (2): 402–3. PMID8586454.
Krutovskikh V, Mironov N, Yamasaki H (August 1996). "Human connexin 37 is polymorphic but not mutated in tumours". Carcinogenesis. 17 (8): 1761–3. doi:10.1093/carcin/17.8.1761. PMID8761439.
Simon AM, Goodenough DA, Li E, Paul DL (February 1997). "Female infertility in mice lacking connexin 37". Nature. 385 (6616): 525–9. doi:10.1038/385525a0. PMID9020357.
van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ (April 1998). "Tumour necrosis factor alpha alters the expression of connexin43, connexin40, and connexin37 in human umbilical vein endothelial cells". Cytokine. 10 (4): 258–64. doi:10.1006/cyto.1997.0287. PMID9617570.
Boerma M, Forsberg L, Van Zeijl L, Morgenstern R, De Faire U, Lemne C, Erlinge D, Thulin T, Hong Y, Cotgreave IA (August 1999). "A genetic polymorphism in connexin 37 as a prognostic marker for atherosclerotic plaque development". Journal of Internal Medicine. 246 (2): 211–8. doi:10.1046/j.1365-2796.1999.00564.x. PMID10447790.
Tsai MY, Lan KC, Huang KE, Huang FJ, Kung FT, Chang SY (December 2003). "Significance of mRNA levels of connexin37, connexin43, and connexin45 in luteinized granulosa cells of controlled hyperstimulated follicles". Fertility and Sterility. 80 (6): 1437–43. doi:10.1016/j.fertnstert.2003.05.015. PMID14667880.
Seul KH, Kang KY, Lee KS, Kim SH, Beyer EC (July 2004). "Adenoviral delivery of human connexin37 induces endothelial cell death through apoptosis". Biochemical and Biophysical Research Communications. 319 (4): 1144–51. doi:10.1016/j.bbrc.2004.05.097. PMID15194487.
Kameritsch P, Khandoga N, Nagel W, Hundhausen C, Lidington D, Pohl U (April 2005). "Nitric oxide specifically reduces the permeability of Cx37-containing gap junctions to small molecules". Journal of Cellular Physiology. 203 (1): 233–42. doi:10.1002/jcp.20218. PMID15481066.